Mupirocin-resistant Staphylococcus aureus in Africa: a systematic review and meta-analysis

Antimicrobial Resistance and Infection Control
Adebayo O ShittuAyodele O Olatimehin

Abstract

Mupirocin is widely used for nasal decolonization of Staphylococcus aureus to prevent subsequent staphylococcal infection in patients and healthcare personnel. However, the prolonged and unrestricted use has led to the emergence of mupirocin-resistant (mupR) S. aureus. The aim of this systematic review was to investigate the prevalence, phenotypic and molecular characteristics, and geographic spread of mupR S. aureus in Africa. We examined five electronic databases (EBSCOhost, Google Scholar, ISI Web of Science, MEDLINE, and Scopus) for relevant English articles on screening for mupR S. aureus from various samples in Africa. In addition, we performed random effects meta-analysis of proportions to determine the pooled prevalence of mupR S. aureus in Africa. The search was conducted until 3 August 2016. We identified 43 eligible studies of which 11 (26%) were obtained only through Google Scholar. Most of the eligible studies (28/43; 65%) were conducted in Nigeria (10/43; 23%), Egypt (7/43; 16%), South Africa (6/43; 14%) and Tunisia (5/43; 12%). Overall, screening for mupR S. aureus was described in only 12 of 54 (22%) African countries. The disk diffusion method was the widely used technique (67%; 29/43) for the detection of mupR...Continue Reading

References

Aug 1, 1989·Antimicrobial Agents and Chemotherapy·H RodeS Cywes
Nov 1, 1995·The Journal of International Medical Research·N El Ferghani
Oct 6, 1997·BMJ : British Medical Journal·M EggerC Minder
Aug 26, 1998·The New England Journal of Medicine·F D Lowy
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Jul 17, 2004·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Christina Scheel ZinnUNKNOWN Sarisa Study Group
Nov 29, 2005·The Lancet Infectious Diseases·Heiman F L WertheimJan L Nouwen
Jul 22, 2009·PLoS Medicine·David MoherUNKNOWN PRISMA Group
Nov 16, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·K Ben SlamaC Torres
Jan 1, 2010·The Libyan Journal of Medicine·Mohamed O AhmedYousef M Abouzeed
May 7, 2011·BMC Microbiology·Adebayo O ShittuUlrich Nübel
Jul 15, 2011·Médecine et maladies infectieuses·K SoulyL Benamar
Jul 26, 2011·BMJ : British Medical Journal·Jonathan A C SterneJulian P T Higgins
Jan 19, 2012·Antimicrobial Agents and Chemotherapy·Christine SeahRoberto G Melano
Sep 13, 2013·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Teresa ConceiçãoMarta Aires-de-Sousa
Oct 16, 2013·Diagnostic Microbiology and Infectious Disease·Adeola RajiPatrick Basset
Oct 23, 2013·The Journal of Hospital Infection·D J Hetem, M J M Bonten
Mar 22, 2014·Journal of the American Society of Nephrology : JASN·Ioannis M ZacharioudakisEleftherios Mylonakis
Jul 25, 2014·Antimicrobial Resistance and Infection Control·Alexander M AikenHajo Grundmann
Nov 19, 2014·International Journal of Pediatrics·Mouna Ben NejmaMaha Mastouri
Feb 7, 2015·PLoS Neglected Tropical Diseases·Nana Ama AmissahYmkje Stienstra
Jul 5, 2015·The Journal of Antimicrobial Chemotherapy·T PoovelikunnelH Humphreys
Sep 1, 2015·The Journal of Antimicrobial Chemotherapy·John HughesOlga Tosas Auguet
Jan 29, 2016·Clinical Microbiology Reviews·Edward J Septimus, Marin L Schweizer

❮ Previous
Next ❯

Citations

Mar 15, 2020·Antimicrobial Resistance and Infection Control·Shima M AbdulgaderMae Newton-Foot
Oct 22, 2019·Assay and Drug Development Technologies·Somdutt MujwarAlekh Gour

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

Academic
StatsDirect
Google Scholar

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.